UnknownPhase 3NCT00004219

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

Studying Germ cell tumor of testis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Simbec Research
Principal Investigator
David P. Dearnaley, MD, FRCP, FRCR
Royal Marsden NHS Foundation Trust
Intervention
granisetron hydrochloride(drug)
Enrollment
150 enrolled
Eligibility
18-70 years · MALE

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004219 on ClinicalTrials.gov

Other trials for Germ cell tumor of testis

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor of testis

← Back to all trials